zuma-5: axi-cel for r/r inhl
Published 3 years ago • 120 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
1:20
axi-cel in r/r fl: an updated comparison of zuma-5 and the scholar-5 external control cohort
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
3:46
zuma-5 update: retreatment of r/r inhl with axi-cel
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
4:23
how to perform daily maintenance on the horiba yumizen (2023)
-
2:00
saa test video
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
0:54
zuma-3 end of phase i results: axi-cel for r/r all
-
1:34
zuma-1 update: safety data of axi-cel in patients with r/r dlbcl
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
4:03
axi-cel plus rituximab for r/r lbcl and updates from the zuma-14 study
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:21
approval of axi-cel in second-line for r/r lbcl & label update
-
1:34
recent and upcoming data on axi-cel for patients with nhl